Loading provider…
Loading provider…
Medical Oncology Physician in Washington, DC
NPI: 1154610467Primary Practice Location
MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL
3800 Reservoir Rd NW, Washington, DC
Primary Employer
Regional Cancer Care Associates, L.L.C.
regionalcancercare.org
HQ Phone
Get MD Kieron's Phone Numberphone_androidMobile
Get MD Kieron's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 112 | 297 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 45 | 210 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 37 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 28 | 28 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 25 | 28 |
Authors: Mark Roschewski, Wyndham Wilson, Milos Miljkovic
Journal: Leuk Lymphoma
Publication Date: 2019-06-17
Authors: Jean Yared, Saurabh Dahiya, Aaron Rapoport, Wengen Chen, Djordje Atanackovic, Silke Niederhaus, Michael Kallen
Journal: Hum Vaccin Immunother
Publication Date: 2023-06-06
Lead Sponsor: Georgetown University
Collaborators: AbbVie, Pharmacyclics LLC., Hackensack Meridian Health
Intervention / Treatment: DRUG: Venetoclax, DRUG: Ibrutinib
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, BIOLOGICAL: Filgrastim, DRUG: Doxorubicin Hydrochloride, BIOLOGICAL: Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor Cells
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Flavopiridol